Literature DB >> 33989079

Mechanistic insights into cell-free hemoglobin-induced injury during septic shock.

Jeffrey Wang1, Willard N Applefeld1, Junfeng Sun1, Steve B Solomon1, Jing Feng1, Zoe G Couse1, Thomas F Risoleo2, Robert L Danner1, Jesús Tejero3, Juan Lertora4, Elmira Alipour5, Swati Basu5, Vandana Sachdev6, Daniel B Kim-Shapiro5, Mark T Gladwin3, Harvey G Klein7, Charles Natanson1.   

Abstract

Cell-free hemoglobin (CFH) levels are elevated in septic shock and are higher in nonsurvivors. Whether CFH is only a marker of sepsis severity or is involved in pathogenesis is unknown. This study aimed to investigate whether CFH worsens sepsis-associated injuries and to determine potential mechanisms of harm. Fifty-one, 10-12 kg purpose-bred beagles were randomized to receive Staphylococcus aureus intrapulmonary challenges or saline followed by CFH infusions (oxyhemoglobin >80%) or placebo. Animals received antibiotics and intensive care support for 96 h. CFH significantly increased mean pulmonary arterial pressures and right ventricular afterload in both septic and nonseptic animals, effects that were significantly greater in nonsurvivors. These findings are consistent with CFH-associated nitric oxide (NO) scavenging and were associated with significantly depressed cardiac function, and worsened shock, lactate levels, metabolic acidosis, and multiorgan failure. In septic animals only, CFH administration significantly increased mean alveolar-arterial oxygenation gradients, also to a significantly greater degree in nonsurvivors. CFH-associated iron levels were significantly suppressed in infected animals, suggesting that bacterial iron uptake worsened pneumonia. Notably, cytokine levels were similar in survivors and nonsurvivors and were not predictive of outcome. In the absence and presence of infection, CFH infusions resulted in pulmonary hypertension, cardiogenic shock, and multiorgan failure, likely through NO scavenging. In the presence of infection alone, CFH infusions worsened oxygen exchange and lung injury, presumably by supplying iron that promoted bacterial growth. CFH elevation, a known consequence of clinical septic shock, adversely impacts sepsis outcomes through more than one mechanism, and is a biologically plausible, nonantibiotic, noncytokine target for therapeutic intervention.NEW & NOTEWORTHY Cell-free hemoglobin (CFH) elevations are a known consequence of clinical sepsis. Using a two-by-two factorial design and extensive physiological and biochemical evidence, we found a direct mechanism of injury related to nitric oxide scavenging leading to pulmonary hypertension increasing right heart afterload, depressed cardiac function, worsening circulatory failure, and death, as well as an indirect mechanism related to iron toxicity. These discoveries alter conventional thinking about septic shock pathogenesis and provide novel therapeutic approaches.

Entities:  

Keywords:  cell-free hemoglobin; iron; septic shock

Mesh:

Substances:

Year:  2021        PMID: 33989079      PMCID: PMC8289364          DOI: 10.1152/ajpheart.00092.2021

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  46 in total

1.  Redox biology of blood.

Authors:  Abdu I Alayash
Journal:  Antioxid Redox Signal       Date:  2004-12       Impact factor: 8.401

Review 2.  Non-transferrin bound iron: a key role in iron overload and iron toxicity.

Authors:  Pierre Brissot; Martine Ropert; Caroline Le Lan; Olivier Loréal
Journal:  Biochim Biophys Acta       Date:  2011-08-09

Review 3.  Anti-inflammatory therapies to treat sepsis and septic shock: a reassessment.

Authors:  F Zeni; B Freeman; C Natanson
Journal:  Crit Care Med       Date:  1997-07       Impact factor: 7.598

4.  Autologous transfusion of stored red blood cells increases pulmonary artery pressure.

Authors:  Lorenzo Berra; Riccardo Pinciroli; Christopher P Stowell; Lin Wang; Binglan Yu; Bernadette O Fernandez; Martin Feelisch; Cristina Mietto; Eldad A Hod; Daniel Chipman; Marielle Scherrer-Crosbie; Kenneth D Bloch; Warren M Zapol
Journal:  Am J Respir Crit Care Med       Date:  2014-10-01       Impact factor: 21.405

5.  Stressed erythrophagocytosis induces immunosuppression during sepsis through heme-mediated STAT1 dysregulation.

Authors:  Tolani F Olonisakin; Tomeka Suber; Shekina Gonzalez-Ferrer; Zeyu Xiong; Hernán F Peñaloza; Rick van der Geest; Yuting Xiong; David O Osei-Hwedieh; Jesús Tejero; Matthew R Rosengart; Wendy M Mars; Daria Van Tyne; Andreas Perlegas; Samuel Brashears; Daniel B Kim-Shapiro; Mark T Gladwin; Michael A Bachman; Eldad A Hod; Claudette St Croix; Yulia Y Tyurina; Valerian E Kagan; Rama K Mallampalli; Anuradha Ray; Prabir Ray; Janet S Lee
Journal:  J Clin Invest       Date:  2021-01-04       Impact factor: 14.808

Review 6.  Anti-inflammatory therapies in sepsis and septic shock.

Authors:  B D Freeman; C Natanson
Journal:  Expert Opin Investig Drugs       Date:  2000-07       Impact factor: 6.206

7.  Association between cell-free hemoglobin, acetaminophen, and mortality in patients with sepsis: an observational study.

Authors:  David R Janz; Julie A Bastarache; Josh F Peterson; Gillian Sills; Nancy Wickersham; Addison K May; L Jackson Roberts; Lorraine B Ware
Journal:  Crit Care Med       Date:  2013-03       Impact factor: 7.598

8.  Free hemoglobin concentration in severe sepsis: methods of measurement and prediction of outcome.

Authors:  Michael Adamzik; Tim Hamburger; Frank Petrat; Jürgen Peters; Herbert de Groot; Matthias Hartmann
Journal:  Crit Care       Date:  2012-07-16       Impact factor: 9.097

9.  Haptoglobin therapy has differential effects depending on severity of canine septic shock and cell-free hemoglobin level.

Authors:  Kenneth E Remy; Irene Cortés-Puch; Junfeng Sun; Jing Feng; Juan J Lertora; Thomas Risoleo; Julia Katz; Swati Basu; Xiaohua Liu; Andreas Perlegas; Daniel B Kim-Shapiro; Harvey G Klein; Charles Natanson; Steven B Solomon
Journal:  Transfusion       Date:  2019-10-22       Impact factor: 3.337

Review 10.  The role of red blood cells and cell-free hemoglobin in the pathogenesis of ARDS.

Authors:  David R Janz; Lorraine B Ware
Journal:  J Intensive Care       Date:  2015-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.